Ledger.Open graph →
SEC Form D · filed November 1, 2019

Hoverink Biotechnologies, Inc

Offering
$4.1M
Sold
—
Exemption
Rule 506(b)
Industry
Hospitals and Physicians
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Davidra N. Sajna · Los Angeles, CAExec · DirectorDebbie Mae Carter · Los Angeles, CAExec · DirectorCyrus Sajna · Los Angeles, CAExec · DirectorAEI Net Lease Portfolio XI Depositor, LLC · St. Paul, MNExec · DirectorWilliam A. Timmerman Iii · Newtown Square, PAExec · DirectorSteven Jacolow · Tampa, FLExec · DirectorHans P. Morefield · East Rochester, NYExec · DirectorJohn P. Holton · East Rochester, NYExec · DirectorTimothy G. Tyler · Needham, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗